Alumis Inc. Common Stock (ALMS) support and resistance · rev $3.4M
Alumis Inc. Common Stock (ALMS) is a biotechnology company listed on US.
This page maps Alumis Inc. Common Stock (ALMS) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ALMS revenue for 2026-06-30 was $3.4M. Net income was -$235.3M. Revenue was up 95.5% from 2026-03-31 to 2026-06-30. ALMS currently screens at market cap $311.6M.
ALMS currently screens at market cap $311.6M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ALMS 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ALMS quote page for the session range and the stock page for the full model.
Not investment advice.